Visit the RavenQuest BioMed Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
VANCOUVER, British Columbia, July 11, 2018 (GLOBE NEWSWIRE) — RavenQuest BioMed Inc. (CSE:RQB) (OTCQB:RVVQF) (Frankfurt:1IT) (the “Company” or “RavenQuest”) is pleased to announce that its wholly owned subsidiary, Bloomera Inc. (“Bloomera”), has signed a memorandum of understanding (the “MOU”) with the British Columbia Liquor Distribution Branch (“BCLDB”) to pursue the wholesale distribution of cannabis produced by Bloomera. It is expected that the agreement to be reached with BCLDB will cover the first 12 months of the legalized adult use cannabis market in Canada and see Bloomera sell all of its production over that period to the BCLDB. The MOU provides that Bloomera will supply a broad assortment of cultivars and end products to the BCLDB.
The BCLDB is responsible for regulating private retail cannabis licensing and the distribution of cannabis to retail stores in British Columbia’s legal adult use recreational cannabis marketplace. The MOU does not represent a binding purchase agreement, and any distribution of cannabis products to the BCLDB is subject to the negotiation of such an agreement on the terms specified by the BCLDB. The Company will provide additional information regarding the BCLDB supply and distribution process as it becomes available.
We are delighted to be working with the BCLDB in pursuit of providing British Columbians with the premium quality cannabis that will come out of our Bloomera facility. Word is getting out that RavenQuest’s grow methodologies are unparalleled in the industry.
George Robinson, CEO of RavenQuest
“We have a deep relationship and understanding of the cannabis plant and the science that goes into delivering high quality and repeatable client experiences. This sets us apart as an organization and is about to be appreciated by the consumer as our exceptional cannabis reaches store shelves across British Columbia. We couldn’t be happier to be working with the BCLDB, which has been a tremendous group to work with throughout the negotiation process,” Robinson continued.
About RavenQuest BioMed Inc.
RavenQuest is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development. RavenQuest is a licensed producer with facilities located in Markham, Ontario and Edmonton, Alberta. RavenQuest maintains a research partnership with Montreal’s McGill University focused upon cultivar (strain) recognition, plant stabilization and yield maximization of the cannabis plant.
The Company focuses on partnerships with Indigenous communities and entered into an MOU to construct a cannabis production facility on sovereign land of Fort McMurray First Nation #468. RavenQuest has also recently entered into an LOI to pursue the acquisition of Western Agripharma Ltd., a late stage application with a production facility under construction on British Columbia’s sunshine coast.
The most reliable, fact-based information on RavenQuest BioMed found only on its Investor Dashboard.
Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.